Efficacy, safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir for HIV pre-exposure prophylaxis in transgender women: a secondary analysis of the HPTN 083 trial
Mark A. Marzinke(Family Health International 360), Sybil Hosek(University of Illinois Chicago), Susan L. Ford(Research Triangle Park Foundation), Juan Carlos Hinojosa Boyer, Christina Psaros(Harvard University), Kailazarid Gomez Feliciano(Family Health International 360), Andrea Jennings(Family Health International 360), Breno Santos(Hospital Nossa Senhora da Conceição), Adeola Adeyeye(National Institutes of Health), Myron S. Cohen(University of North Carolina at Chapel Hill), Beatriz Grinsztejn(Fundação Oswaldo Cruz), Paul Goepfert(University of Maryland, Baltimore), Suwat Chariyalertsak(Chiang Mai University), Carolina Coutinho(Fundação Oswaldo Cruz), Bernardo Maia(Instituto de Infectologia Emílio Ribas), Steven A. Safren(University of Miami), Javier Valencia(Asociación Civil Impacta Salud y Educación), Keren Middelkoop(Desmond Tutu HIV Foundation), Raphael J. Landovitz(APLA Health), Trần Việt Hà(University of North Carolina at Chapel Hill), Marybeth McCauley(Family Health International 360), James F. Rooney(Gilead Sciences (United States)), Esper G. Kallás(Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo), Julie Franks(Harlem United), Emília M. Jalil(Fundação Oswaldo Cruz), Jonathan Lucas(Family Health International 360), Deborah Donnell(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Chaiwat Ungsedhapand, Taimur Khan(Fenway Health), Milagros Erika Matta Aguirre, Philip A. Sullivan(Johns Hopkins University), Marcelo Losso(UCLA Medical Center), Susan H. Eshleman(Johns Hopkins University), Brett Hanscom(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Alex R. Rinehart, Yashna Singh(Desmond Tutu HIV Foundation), Zhe Wang(Zhongda Hospital Southeast University), José Valdez Madruga(Hospital Nacional Dos de Mayo), Naiymah Sanchez(Family Health International 360), Y.P. Ramirez(Johns Hopkins University), Paul A. Richardson(Johns Hopkins University), Jorge A. Gallardo-Cartagena(National University of San Marcos), María Inés Figueroa(Fundación Huésped), Nadir Cardozo(Fundación Huésped)
Cited by 14
Related Papers
Prevention of HIV-1 Infection with Early Antiretroviral Therapy
|New England Journal of Medicine|2011|7k
Antiretroviral Prophylaxis for HIV Prevention in Heterosexual Men and Women
|New England Journal of Medicine|2012|3.3k
Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19
|New England Journal of Medicine|2021|2.6k
Antiretroviral Therapy for the Prevention of HIV-1 Transmission
|New England Journal of Medicine|2016|1.7k
On-Demand Preexposure Prophylaxis in Men at High Risk for HIV-1 Infection
|New England Journal of Medicine|2015|1.6k